Ceritinib dihydrochloride (Standard), CAS [[1380575-43-8]] Preis auf Anfrage

Produktübersicht

• Artikelname: Ceritinib dihydrochloride (Standard), CAS [[1380575-43-8]] Preis auf Anfrage
• Artikelnummer: MCE-HY-15656AR
• Hersteller Artikelnummer: HY-15656AR
• Alternativnummer: MCE-HY-15656AR-100MG,MCE-HY-15656AR-25MG,MCE-HY-15656AR-50MG,MCE-HY-15656AR-5MG,MCE-HY-15656AR-10MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien

Produktbeschreibung

Ceritinib dihydrochloride (Standard) is the analytical standard of Ceritinib dihydrochloride. This product is intended for research and analytical applications. Ceritinib dihydrochloride (LDK378 dihydrochloride) is a selective, orally bioavailable and ATP-competitive ALK tyrosine kinase inhibitor with an IC50 of 200 pM. Ceritinib dihydrochloride (LDK378 dihydrochloride) also inhibits IGF-1R, InsR, and STK22D with IC50 values of 8, 7, and 23 nM, respectively. Ceritinib dihydrochloride (LDK378 dihydrochloride) shows great antitumor potency[1][2].

Produkteigenschaften

• Molekulargewicht: 631.06
• CAS Nummer: [1380575-43-8]
• Formel: C28H38Cl3N5O3S
• Target-Kategorie: Anaplastic lymphoma kinase (ALK),IGF-1R,Insulin Receptor,Reference Standards

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference Standards